Testosterone Cypionate Injection Recalled Without Approved Application
Advanced Pharmaceutical Technology, Inc. is recalling TESTO-200 (Testosterone Cypionate Injection USP, 200mg/ml) because it was marketed without an approved NDA or ANDA.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall. Marketing a drug without an approved NDA/ANDA is a serious regulatory violation that poses a significant health risk because the product has not undergone FDA review for safety and efficacy, meeting the threshold for Severe classification.
Plain-English summary
Advanced Pharmaceutical Technology, Inc. is recalling TESTO-200, Testosterone Cypionate Injection USP (2000mg/10ml, 200mg/ml) distributed in New York and New Jersey. The product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
The affected product includes 26 vials with Lot P-24-1 and expiration date 02/28/2027. The product is supplied in 10ml multidose vials for intramuscular injection and is prescription-only.
Patients currently using this product should consult their healthcare provider before making any changes to their treatment. Healthcare providers should contact Advanced Pharmaceutical Technology, Inc. at the address listed for further information about alternative therapeutic options.
The recalled product
- Product
- TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml multidose vial per carton, For intramuscular injection only, Rx Only, ADVANCED PHARMACEUTICAL TECHNOLOGY, INC., 132 South Central Avenue, Elmsford, NY 10523. NDC 57377-200-01
- Manufacturer
- Advanced Pharmaceutical Technology, Inc.
- Hazard
- unapproved-drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot P-24-1
- Exp. 02/28/2027
Distribution
Distributed in 2 states:
- NJ
- NY
Related recalls
Same category
- SevereFDA Recalls Rohto Dry-Aid Eye Drops Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighLEVOTHYROXINE SODIUM Tablets Recalled Due to Subpotent Drug Content
FDA (Drugs) · 2026-07-29
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-07-29
- SevereDietary Supplement Modern Warrior Ready Recalled for Unapproved Ingredients
FDA (Food) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29